Rhumbline Advisers Acquires 633 Shares of Mettler-Toledo International, Inc. $MTD

Rhumbline Advisers increased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 1.5% during the third quarter, Holdings Channel.com reports. The fund owned 41,871 shares of the medical instruments supplier’s stock after purchasing an additional 633 shares during the quarter. Rhumbline Advisers’ holdings in Mettler-Toledo International were worth $51,401,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bank of New York Mellon Corp grew its position in shares of Mettler-Toledo International by 71.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Norges Bank acquired a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $360,126,000. Rakuten Investment Management Inc. bought a new stake in shares of Mettler-Toledo International in the third quarter valued at approximately $121,021,000. Corient Private Wealth LLC grew its position in Mettler-Toledo International by 91.8% during the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock worth $164,775,000 after buying an additional 67,149 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in Mettler-Toledo International by 752.2% during the 3rd quarter. Thrivent Financial for Lutherans now owns 73,586 shares of the medical instruments supplier’s stock worth $90,335,000 after acquiring an additional 64,951 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,362.59 on Friday. The company’s 50 day moving average price is $1,416.03 and its two-hundred day moving average price is $1,363.09. The firm has a market capitalization of $27.70 billion, a P/E ratio of 32.35, a P/E/G ratio of 2.85 and a beta of 1.42. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The company had revenue of $1.13 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the prior year, the company earned $12.41 EPS. Mettler-Toledo International’s revenue was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, insider La Guerroniere Marc De sold 6,055 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider owned 187 shares in the company, valued at $278,289.66. This trade represents a 97.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shawn Vadala sold 1,025 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $1,452.00, for a total transaction of $1,488,300.00. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,678,176. This represents a 16.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 9,116 shares of company stock worth $13,473,111. 1.94% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th. Morgan Stanley cut their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research report on Tuesday. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective on the stock in a research note on Monday, December 15th. Wall Street Zen upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Citigroup upped their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $1,435.42.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.